User profiles for Douglas A. Levine

Douglas A Levine MD

NYU Langone Health
Verified email at nyumc.org
Cited by 88084

Integrated genomic characterization of endometrial carcinoma

, … Garg Karuna 52 Soslow Robert A. 52 Levine Douglas … - Nature, 2013 - nature.com
We performed an integrated genomic, transcriptomic and proteomic characterization of 373
endometrial carcinomas using array- and sequencing-based technologies. Uterine serous …

Inferring tumour purity and stromal and immune cell admixture from expression data

…, V Treviño, H Shen, PW Laird, DA Levine… - Nature …, 2013 - nature.com
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue
and not only perturb the tumour signal in molecular studies but also have an important role in …

[PDF][PDF] An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics

…, AD Cherniack, AJ Kovatich, CC Benz, DA Levine… - Cell, 2018 - cell.com
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …

Absolute quantification of somatic DNA alterations in human cancer

…, BA Weir, R Beroukhim, D Pellman, DA Levine… - Nature …, 2012 - nature.com
We describe a computational method that infers tumor purity and malignant cell ploidy
directly from analysis of somatic DNA alterations. The method, named ABSOLUTE, can detect …

OncoKB: a precision oncology knowledge base

…, G Iyer, YY Janjigian, T Kaley, DA Levine… - JCO precision …, 2017 - ascopubs.org
Purpose With prospective clinical sequencing of tumors emerging as a mainstay in cancer
care, an urgent need exists for a clinical support tool that distills the clinical implications …

Evaluating cell lines as tumour models by comparison of genomic profiles

S Domcke, R Sinha, DA Levine, C Sander… - Nature …, 2013 - nature.com
Cancer cell lines are frequently used as in vitro tumour models. Recent molecular profiles of
hundreds of cell lines from The Cancer Cell Line Encyclopedia and thousands of tumour …

Rethinking ovarian cancer: recommendations for improving outcomes

…, SB Kaye, CJ Lord, E Lengyel, DA Levine… - Nature Reviews …, 2011 - nature.com
There have been major advances in our understanding of the cellular and molecular biology
of the human malignancies that are collectively referred to as ovarian cancer. At a recent …

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

…, BY Karlan, A Kaye, E Lengyel, DA Levine… - Nature reviews …, 2015 - nature.com
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths,
and overall survival has not changed significantly for several decades. In this Opinion article…

Resistance to therapy caused by intragenic deletion in BRCA2

…, CJ Lord, R Natrajan, R Vatcheva, DA Levine… - Nature, 2008 - nature.com
Cells with loss of BRCA2 function are defective in homologous recombination (HR) and are
highly sensitive to inhibitors of poly(ADP-ribose) polymerase (PARP) 1 , 2 , which provides …

Integrated proteogenomic characterization of human high-grade serous ovarian cancer

…, L Cope, A Pandey, B Zhang, MP Snyder, DA Levine… - Cell, 2016 - cell.com
To provide a detailed analysis of the molecular components and underlying mechanisms
associated with ovarian cancer, we performed a comprehensive mass-spectrometry-based …